How kind and reasonable application of antihypertensive drug
Application of antihypertensive drugs lower blood pressure is the main therapy for hypertension. According to the United States recently conducted a large-scale survey and found that a reasonable application of antihypertensive drugs and patients with hypertension do not have to buck the drug compared with patients with hypertension, the average life expectancy can be improved. Therefore, was diagnosed with hypertension and the doctors decided who would take antihypertensive drug treatment, we must adhere to application of antihypertensive drugs. In the course of treatment, should adhere to the following "five to three instead of" principles:
1, according to a different type, stage and whether the existence of complications, doctors decided to adopt the appropriate antihypertensive drugs, their abuse should not be arbitrarily.
2, mild to moderate hypertension, to choose a pressure-relief drugs, doses from the beginning is gradually increasing doses to achieve relief purposes, and then gradually to maintain the capacity to maintain blood pressure will not increase.
3, the heavier conditions to the application of several antihypertensive drugs, can improve efficacy, reduce side effects.
4, should pay close attention to the application of antihypertensive drugs in the course of the various possible adverse reactions, so that timely identified and corrected.
5, in the course of medication, to keep blood pressure measurement, in accordance with changes in blood pressure drug dosage adjustments.
6, not with self-increase or decrease in dose to avoid trouble. Self-feeling is not reliable, such as dizziness, high blood pressure can occur when the dizziness and low blood pressure, will feel dizzy.
7, Do not arbitrarily change the type of drug or dose.
8, do not rely on rumors and ads, not to disable the antihypertensive drug use Pianfang, secret or health products instead of antihypertensive drugs, so as to avoid serious consequences.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment